Evidence map›Paper›PMID 29516759›Full record

ArticleDrug delivery2018

Combined sustained release of BMP2 and MMP10 accelerates bone formation and mineralization of calvaria critical size defect in mice.

Ricardo Reyes, Jose Antonio Rodríguez, Josune Orbe, María Rosa Arnau, Carmen Évora, Araceli Delgado

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. eLife · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ricardo Reyesa Department of Biochemistry, Microbiology, Cell Biology and Genetics , Universidad de La Laguna , La Laguna , Spain.ORCID http://orcid.org/0000-0002-1765-3257
Jose Antonio Rodríguezc Laboratorio de Aterotrombosis, Área de Ciencias Cardiovasculares, CIMA-Universidad de Navarra , Pamplona , Spain.ORCID http://orcid.org/0000-0002-2094-264X
Josune Orbec Laboratorio de Aterotrombosis, Área de Ciencias Cardiovasculares, CIMA-Universidad de Navarra , Pamplona , Spain.ORCID http://orcid.org/0000-0001-6300-7670
María Rosa Arnauf Servicio de Estabulario, Universidad de La Laguna , La Laguna , Spain.
Carmen Évorab Institute of Biomedical Technologies (ITB), Center for Biomedical Research of the Canary Islands (CIBICAN), Universidad de La Laguna , La Laguna , Spain.ORCID http://orcid.org/0000-0002-9347-4672
Araceli Delgadob Institute of Biomedical Technologies (ITB), Center for Biomedical Research of the Canary Islands (CIBICAN), Universidad de La Laguna , La Laguna , Spain.ORCID http://orcid.org/0000-0001-7045-6933
Universidad de La Laguna · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effect of dual delivery of bone morphogenetic protein-2 (BMP-2) and matrix metalloproteinase 10 (MMP10) on bone regeneration was investigated in a murine model of calvarial critical-size defect, hypothesizing that it would result in an enhanced bone formation. Critical-size calvarial defects (4 mm diameter) were created in mice and PLGA microspheres preloaded with either BMP-2, MMP10 or a microsphere combination of both were transplanted into defect sites at different doses. Empty microspheres were used as the negative control. Encapsulation efficiency was assessed and in vivo release kinetics of BMP-2 and MMP10 were examined over 14 days. Histological analyses were used to analyze bone formation after four and eight weeks. Combination with MMP10 (30 ng) significantly enhanced BMP-2 (600 ng)-mediated osteogenesis, as confirmed by the increase in percentage of bone fill (p < .05) at four weeks. Moreover, it also increased mineral apposition rate (p < .05), measured by double labeling with tetracycline and calceine. MMP10 accelerates bone repair by enhancing BMP-2-promoted bone healing and improving the mineralization rate. In conclusion combination of MMP10 and BMP-2 may become a promising strategy for repair and regeneration of bone defects.

Indexed as

AnimalsBone Morphogenetic Protein 2Bone RegenerationCalcification, PhysiologicDelayed-Action PreparationsDrug CombinationsHEK293 CellsHumansMaleMatrix Metalloproteinase 10MiceOsteogenesisSkullBMP2 protein, humanBone Morphogenetic Protein 2Delayed-Action PreparationsDrug CombinationsMatrix Metalloproteinase 10MMP10 protein, humanBMP-2bone repairhistomorphometrymineralizationMMP10sustained release

Identifiers

PMID29516759
PMCPMC6058487
OpenAlexW2792938657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.